190 related articles for article (PubMed ID: 32800789)
1. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases.
Xu W; Chen S; Wang X; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Pharmacol Ther; 2021 Jan; 217():107659. PubMed ID: 32800789
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
[TBL] [Abstract][Full Text] [Related]
3. Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.
Xu W; Chen S; Wang X; Wu H; Yamada H; Hirano T
Steroids; 2020 Nov; 163():108714. PubMed ID: 32818521
[TBL] [Abstract][Full Text] [Related]
4. Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P-glycoprotein and mitogen-activated protein kinase in mitogen-activated human peripheral blood mononuclear cells.
Xu W; Meng K; Tu Y; Tanaka S; Onda K; Sugiyama K; Hirano T; Yamada H
Eur J Pharmacol; 2017 Jul; 807():102-108. PubMed ID: 28408143
[TBL] [Abstract][Full Text] [Related]
5. Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells.
Xu W; Wang X; Chen S; Wu H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Eur J Pharmacol; 2020 Aug; 881():173232. PubMed ID: 32525004
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling.
Li X; Jin Q; Wu YL; Sun P; Jiang S; Zhang Y; Zhang DQ; Zhang YJ; Lian LH; Nan JX
Int Immunopharmacol; 2016 Jul; 36():263-270. PubMed ID: 27179306
[TBL] [Abstract][Full Text] [Related]
7. Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells.
Ho LJ; Chang DM; Lee TC; Chang ML; Lai JH
Eur J Pharmacol; 1999 Feb; 367(2-3):389-98. PubMed ID: 10079015
[TBL] [Abstract][Full Text] [Related]
8. Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
Kou B; Liu W; He W; Zhang Y; Zheng J; Yan Y; Zhang Y; Xu S; Wang H
Oncol Rep; 2016 May; 35(5):2880-6. PubMed ID: 26935264
[TBL] [Abstract][Full Text] [Related]
9. JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.
Liou JT; Lin CS; Liao YC; Ho LJ; Yang SP; Lai JH
Acta Pharmacol Sin; 2017 Aug; 38(8):1171-1183. PubMed ID: 28603286
[TBL] [Abstract][Full Text] [Related]
10. Bisbenzylisoquinoline alkaloids and P-glycoprotein function: A structure activity relationship study.
Xu W; Chen S; Wang X; Wu H; Yamada H; Hirano T
Bioorg Med Chem; 2020 Jun; 28(12):115553. PubMed ID: 32503690
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
[TBL] [Abstract][Full Text] [Related]
12. Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-κB inactivation.
Gao LN; Feng QS; Zhang XF; Wang QS; Cui YL
J Orthop Res; 2016 Sep; 34(9):1557-68. PubMed ID: 26748661
[TBL] [Abstract][Full Text] [Related]
13. The Potential of Tetrandrine against Gliomas.
Chen Y; Tseng SH
Anticancer Agents Med Chem; 2010 Sep; 10(7):534-42. PubMed ID: 20879981
[TBL] [Abstract][Full Text] [Related]
14. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
[TBL] [Abstract][Full Text] [Related]
15. Absolute configuration of tetrandrine and isotetrandrine influences their anti-proliferation effects in human T cells via different regulation of NF-κB.
Xu W; Kusano J; Chen S; Yamamoto R; Matsuda H; Hara Y; Fujii Y; Hayashi S; Tanaka S; Sugiyama K; Yamada H; Hirano T
Z Naturforsch C J Biosci; 2021 Jan; 76(1-2):21-25. PubMed ID: 33119545
[TBL] [Abstract][Full Text] [Related]
16. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
Kou B; Liu W; Xu X; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q
Oncol Rep; 2017 Nov; 38(5):3137-3143. PubMed ID: 29048631
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-delta in U937 cells.
Jang BC; Lim KJ; Paik JH; Cho JW; Baek WK; Suh MH; Park JB; Kwon TK; Park JW; Kim SP; Shin DH; Song DK; Bae JH; Mun KC; Suh SI
Biochem Pharmacol; 2004 May; 67(10):1819-29. PubMed ID: 15130759
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.
Yu M; Liu T; Chen Y; Li Y; Li W
J Exp Clin Cancer Res; 2018 Jun; 37(1):114. PubMed ID: 29866132
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of T-cell-dependent immune responses by bisbenzylisoquinoline alkaloids in vivo.
Kondo Y; Imai Y; Hojo H; Hashimoto Y; Nozoe S
Int J Immunopharmacol; 1992 Oct; 14(7):1181-6. PubMed ID: 1452403
[TBL] [Abstract][Full Text] [Related]
20. VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.
Toosi B; Zaker F; Alikarami F; Kazemi A; Teremmahi Ardestanii M
Biomed Pharmacother; 2018 Jun; 102():428-437. PubMed ID: 29574283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
